ADMA Biologics Inc (ADMA)
6.73
+0.06
(+0.90%)
USD |
NASDAQ |
May 02, 16:00
6.735
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Gross Profit (TTM): 88.94M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 88.94M |
September 30, 2023 | 72.03M |
June 30, 2023 | 57.04M |
March 31, 2023 | 48.12M |
December 31, 2022 | 35.26M |
September 30, 2022 | 24.60M |
June 30, 2022 | 15.33M |
March 31, 2022 | 6.557M |
December 31, 2021 | 1.173M |
September 30, 2021 | -7.493M |
June 30, 2021 | -9.458M |
March 31, 2021 | -14.16M |
December 31, 2020 | -19.07M |
September 30, 2020 | -13.57M |
June 30, 2020 | -12.69M |
March 31, 2020 | -10.91M |
December 31, 2019 | -10.16M |
September 30, 2019 | -17.59M |
June 30, 2019 | -21.83M |
March 31, 2019 | -22.89M |
December 31, 2018 | -25.21M |
September 30, 2018 | -18.04M |
June 30, 2018 | -19.67M |
March 31, 2018 | -15.62M |
December 31, 2017 | -6.404M |
Date | Value |
---|---|
September 30, 2017 | -5.170M |
June 30, 2017 | 2.593M |
March 31, 2017 | 4.455M |
December 31, 2016 | 4.300M |
September 30, 2016 | 3.996M |
June 30, 2016 | 3.534M |
March 31, 2016 | 3.130M |
December 31, 2015 | 2.866M |
September 30, 2015 | 2.389M |
June 30, 2015 | 2.147M |
March 31, 2015 | 2.183M |
December 31, 2014 | 2.173M |
September 30, 2014 | 1.783M |
June 30, 2014 | 1.666M |
March 31, 2014 | 1.364M |
December 31, 2013 | 1.044M |
September 30, 2013 | 1.046M |
June 30, 2013 | 0.88M |
March 31, 2013 | 0.7108M |
December 31, 2012 | 0.4513M |
September 30, 2012 | 0.3083M |
June 30, 2012 | 0.0926M |
March 31, 2012 | 0.0044M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-21.83M
Minimum
Jun 2019
88.94M
Maximum
Dec 2023
11.16M
Average
-7.493M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Vanda Pharmaceuticals Inc | 177.84M |
ANI Pharmaceuticals Inc | 305.30M |
Ligand Pharmaceuticals Inc | 120.80M |
Puma Biotechnology Inc | 172.96M |
Bristol-Myers Squibb Co | 34.48B |